02367 GIANT BIOGENE
- 39.600
- -0.400-1.00%
GIANT BIOGENE News
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024
GIANT BIOGENE: New Arrangements on Dissemination of Corporate Communications to Non-Registered Shareholders
GIANT BIOGENE: New Arrangements on Dissemination of Corporate Communications to Registered Shareholders
GIANT BIOGENE: Fourth Amended And Restated Memorandum And Articles of Association
GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023 (Updated)
GIANT BIOGENE: Final Dividend for the Year Ended 31 December 2023 (Updated)
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024
GIANT BIOGENE: Next Day Disclosure Return
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024
GIANT BIOGENE: FORM OF PROXY FOR USE AT 2023 ANNUAL GENERAL MEETINGTO BE HELD ON 13 JUNE 2024
GIANT BIOGENE: 2023 Environmental, Social and Governance (ESG) Report
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
GIANT BIOGENE: PROPOSED ADOPTION OF THE AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023
GIANT BIOGENE: Final Dividend for the Year Ended 31 December 2023
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023
Analysis
Price Target
No Data
